Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 568

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Inflammatory Disease Processes and Interactions with Nutrition

Open access
Calder, P. C., Albers, R., Antoine, J.-M., Blum, S., Bourdet-Sicard, R., Ferns, G. A., Folkerts, G., Friedmann, P. S., Frost, G. S., Guarner, F., Løvik, M., Macfarlane, S., Meyer, P. D., M'Rabet, L., Serafini, M., van Eden, W., van Loo, J., Vas Dias, W., Vidry, S., Winklhofer-Roob, B. M., Zhao, J.·2009·British Journal of Nutrition
DOI 10.1017/s0007114509377867
Open this paper in CoChat — free account

Abstract

Inflammation is a stereotypical physiological response to infections and tissue injury; it initiates pathogen killing as well as tissue repair processes and helps to restore homeostasis at infected or damaged sites. Acute inflammatory reactions are usually self-limiting and resolve rapidly, due to the involvement of negative feedback mechanisms. Thus, regulated inflammatory responses are essential to remain healthy and maintain homeostasis. However, inflammatory responses that fail to regulate themselves can become chronic and contribute to the perpetuation and progression of disease. Characteristics typical of chronic inflammatory responses underlying the pathophysiology of several disorders include loss of barrier function, responsiveness to a normally benign stimulus, infiltration of inflammatory cells into compartments where they are not normally found in such high numbers, and overproduction of oxidants, cytokines, chemokines, eicosanoids and matrix metalloproteinases. The levels of these mediators amplify the inflammatory response, are destructive and contribute to the clinical symptoms. Various dietary components including long chain ω-3 fatty acids, antioxidant vitamins, plant flavonoids, prebiotics and probiotics have the potential to modulate predisposition to chronic inflammatory conditions and may have a role in their therapy. These components act through a variety of mechanisms including decreasing inflammatory mediator production through effects on cell signaling and gene expression (ω-3 fatty acids, vitamin E, plant flavonoids), reducing the production of damaging oxidants (vitamin E and other antioxidants), and promoting gut barrier function and anti-inflammatory responses (prebiotics and probiotics). However, in general really strong evidence of benefit to human health through anti-inflammatory actions is lacking for most of these dietary components. Thus, further studies addressing efficacy in humans linked to studies providing greater understanding of the mechanisms of action involved are required.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0007114509377867

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 37 references

Research works printed but not linked: 421

  1. 10.1056/NEJMra020100 · DOI · Paper page
  2. Hlivak, 2005, One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels, Bratisl Lek Listy, 106, 67
  3. 10.1067/mai.2003.389 · DOI · Paper page
  4. 10.1016/S0140-6736(03)13490-3 · DOI · Paper page
  5. 10.1016/S0091-6749(97)70093-9 · DOI · Paper page
  6. 10.1067/mai.2001.115754 · DOI · Paper page
  7. 10.1067/mai.2001.118130 · DOI · Paper page
  8. 10.1046/j.0954-7894.2002.01354.x · DOI
  9. 10.1016/S0091-6749(98)70055-7 · DOI · Paper page
  10. 10.3168/jds.S0022-0302(98)75549-3 · DOI
  11. 10.1159/000069458 · DOI · Paper page
  12. 10.1080/03009740310003695 · DOI
  13. 10.1080/07315724.2003.10719276 · DOI · Paper page
  14. 10.3748/wjg.v10.i10.1521 · DOI
  15. 10.1111/j.1365-2036.2006.02927.x · DOI · Paper page
  16. Tursi, 2004, Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis, Med Sci Monit, 10, I126
  17. 10.1002/ibd.20063 · DOI · Paper page
  18. 10.1136/gut.2005.076604 · DOI · Paper page
  19. 10.1186/1471-230X-4-5 · DOI · Paper page
  20. 10.1097/00005176-200010000-00024 · DOI · Paper page
  21. 10.1046/j.1365-2036.2003.01465.x · DOI · Paper page
  22. 10.1136/gut.53.1.108 · DOI · Paper page
  23. 10.1097/01.mpg.0000228100.04702.f8 · DOI
  24. 10.4049/jimmunol.174.6.3237 · DOI · Paper page
  25. 10.1172/JCI12821 · DOI · Paper page
  26. Matsuguchi, 2003, Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2, Clin Diagn Lab Immunol, 10, 259, 10.1128/CDLI.10.2.259-266.2003 · DOI · Paper page
  27. 10.4049/jimmunol.164.7.3733 · DOI
  28. 10.1111/j.1365-2567.2005.02176.x · DOI
  29. 10.1111/j.1365-2567.2006.02358.x · DOI · Paper page
  30. 10.1038/ni1018 · DOI · Paper page
  31. 10.1016/j.coph.2005.06.009 · DOI
  32. 10.1128/AEM.71.12.8344-8351.2005 · DOI · Paper page
  33. 10.1128/IAI.74.1.425-434.2006 · DOI · Paper page
  34. 10.1016/j.jaci.2005.03.036 · DOI · Paper page
  35. 10.1111/j.1365-2036.2007.03288.x · DOI · Paper page
  36. 10.1136/gut.51.3.405 · DOI · Paper page
  37. 10.1007/s10350-004-6257-2 · DOI · Paper page
  38. 10.1111/j.1471-0528.2006.01004.x · DOI · Paper page
  39. 10.1080/07315724.1999.10718895 · DOI
  40. 10.1159/000083816 · DOI
  41. 10.1038/362801a0 · DOI · Paper page
  42. 10.1016/j.soard.2005.01.001 · DOI
  43. 10.1183/09031936.03.00000903a · DOI
  44. 10.1016/S0168-1605(98)00044-0 · DOI · Paper page
  45. 10.1016/0895-4356(95)00028-3 · DOI
  46. 10.1001/archpedi.1997.02170410041005 · DOI
  47. 10.1046/j.0022-202X.2004.22227.x · DOI
  48. 10.1016/j.bpg.2005.01.006 · DOI
  49. 10.1136/bmj.330.7499.1046 · DOI
  50. 10.1016/S0140-6736(05)17704-6 · DOI
  51. 10.1007/s00394-002-1105-4 · DOI · Paper page
  52. 10.1016/S0002-9343(01)01114-7 · DOI · Paper page
  53. 10.1136/gut.2003.037747 · DOI · Paper page
  54. Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1 · DOI · Paper page
  55. 10.1126/science.7624777 · DOI · Paper page
  56. 10.1136/ard.2004.023044 · DOI
  57. 2003, Coronary Heart Disease Statistics
  58. 10.1126/science.271.5249.665 · DOI · Paper page
  59. 10.1136/bmj.38561.633345.8F · DOI · Paper page
  60. 10.1111/j.1749-6632.1992.tb17098.x · DOI
  61. 10.1073/pnas.81.12.3883 · DOI · Paper page
  62. 10.1016/j.ahj.2003.10.022 · DOI
  63. 10.1038/sj.ejcn.1602250 · DOI
  64. 10.1007/s11745-004-1342-z · DOI
  65. 10.1016/j.ejphar.2005.12.066 · DOI
  66. 10.1136/ard.2003.007740 · DOI · Paper page
  67. Mohamed-Ali, 2005, Cardiovascular Disease: Diet, Nutrition and Emerging Risk Factors, 160
  68. 10.1079/BJN20051400 · DOI
  69. 10.1172/JCI107620 · DOI
  70. Baigent, 2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 · DOI · Paper page
  71. 10.1186/ar578 · DOI
  72. Katsuda, 1992, Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults, Am J Pathol, 140, 907
  73. 10.1007/s11926-004-0008-1 · DOI
  74. 10.1172/JCI200113416 · DOI · Paper page
  75. 10.1164/ajrccm.151.5.7735589 · DOI · Paper page
  76. Macfarlane, 2003, Gut Flora, Nutrition, Immunity and Health
  77. 10.1097/00041433-199810000-00005 · DOI
  78. 10.1513/pats.200504-026SR · DOI · Paper page
  79. 10.1164/rccm.200512-1946OC · DOI · Paper page
  80. 10.1016/j.clnu.2006.01.025 · DOI
  81. 10.1093/ajcn/72.5.1297s · DOI
  82. 10.1136/thx.2006.068205 · DOI
  83. 10.1084/jem.180.6.2359 · DOI · Paper page
  84. 10.7326/0003-4819-142-1-200501040-00110 · DOI · Paper page
  85. 10.1097/00024382-199609010-00004 · DOI
  86. 10.1002/art.11296 · DOI · Paper page
  87. Penn, 1997, Macromolecular transport in the arterial intima: comparison of chronic and acute injuries, Am J Physiol, 272, H1560
  88. Elewaut, 1999, NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria, J Immunol, 163, 1457, 10.4049/jimmunol.163.3.1457 · DOI · Paper page
  89. 10.14310/horm.2002.11190 · DOI
  90. 10.1111/j.1365-2133.1983.tb06823.x · DOI
  91. 10.1167/iovs.02-0822 · DOI · Paper page
  92. 10.1016/S0091-6749(96)70286-5 · DOI
  93. 10.1001/archinte.165.7.725 · DOI · Paper page
  94. 10.1007/BF02818800 · DOI
  95. 10.1038/nm851 · DOI · Paper page
  96. Chan, 1993, Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis, J Immunol, 151, 3345, 10.4049/jimmunol.151.6.3345 · DOI
  97. Edmonds, 1997, Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis, Results of a prospective placebo controlled double blind trial. Ann Rheum Dis, 56, 649
  98. Barrios, 2006, Asthma: pathology and pathophysiology, Arch Pathol Lab Med, 130, 447, 10.5858/2006-130-447-APAP · DOI
  99. 10.1111/j.1365-2567.2004.01925.x · DOI · Paper page
  100. 10.1046/j.1365-2230.2000.00698.x · DOI
  101. 10.1002/art.10085 · DOI
  102. 10.1186/ar86 · DOI
  103. Firestein, 1990, Quantitative analysis of cytokine gene expression in rheumatoid arthritis, J Immunol, 144, 3347, 10.4049/jimmunol.144.9.3347 · DOI · Paper page
  104. 10.1016/S0140-6736(05)17714-9 · DOI
  105. Levine, 1994, Natural Antioxidants in Health and Disease, 469
  106. 10.1016/j.rdc.2004.01.006 · DOI
  107. 10.1161/01.ATV.20.5.1177 · DOI · Paper page
  108. 10.1186/ar1737 · DOI
  109. Sundl, 2005, Effects of mixed tocopherols versus alpha-tocopherol on nuclear factor kappa B activation in mononuclear leukocytes of healthy male volunteers, Clin Nutr, 24, 595
  110. 10.1002/art.1780350702 · DOI · Paper page
  111. 10.1186/ar1767 · DOI · Paper page
  112. 10.1016/0024-3205(82)90723-8 · DOI
  113. 10.4049/jimmunol.172.10.6435 · DOI · Paper page
  114. 10.1016/S0140-6736(94)92405-8 · DOI · Paper page
  115. 10.3109/03009748909092614 · DOI
  116. 10.1016/S0140-6736(98)06343-0 · DOI · Paper page
  117. 10.1097/00041433-200208000-00005 · DOI
  118. 10.1080/13547500110104233 · DOI · Paper page
  119. 10.1136/gut.47.1.63 · DOI · Paper page
  120. 10.1016/S0021-9150(02)00427-6 · DOI · Paper page
  121. 10.1016/0092-8674(92)90391-O · DOI · Paper page
  122. 10.3109/10715768509056534 · DOI
  123. 10.1016/S0009-8981(00)00358-2 · DOI
  124. 10.1093/jn/132.3.540S · DOI
  125. 10.1378/chest.124.4.1373 · DOI
  126. 10.1038/nature01661 · DOI · Paper page
  127. 10.1016/S0140-6736(05)60640-X · DOI
  128. 10.1016/S0140-6736(97)07302-9 · DOI · Paper page
  129. 10.1016/S0891-5849(96)00271-7 · DOI · Paper page
  130. 10.1053/j.gastro.2004.04.015 · DOI · Paper page
  131. 10.1146/annurev.nutr.26.061505.111242 · DOI
  132. Holzapfel, 2006, Probiotics in Food Safety and Human Health, 1
  133. 10.1056/NEJM199606133342401 · DOI · Paper page
  134. 10.1093/jn/104.7.850 · DOI
  135. 10.1161/01.ATV.10.2.178 · DOI
  136. Schultz, 2004, Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats, Clin Diagn Lab Immunol, 11, 581, 10.1128/CDLI.11.3.581-587.2004 · DOI
  137. 10.1164/rccm.200601-072OC · DOI
  138. 10.1038/nm0304-232 · DOI
  139. 10.1016/j.jclinepi.2004.09.015 · DOI
  140. 10.1007/BF02522884 · DOI · Paper page
  141. 10.2337/diabetes.51.1.7 · DOI · Paper page
  142. MacNee, 2004, Clinical Respiratory Medicine, 415
  143. Steinberg, 1989, Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity, N Engl J Med, 320, 915
  144. Lewis, 1990, Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases, N Engl J Med, 323, 645, 10.1056/NEJM199009063231006 · DOI
  145. 10.1016/S0378-8741(99)00154-3 · DOI
  146. Rolfe, 1996, Gastrointentestinal Microbiology
  147. Krutmann, 1996, Sequential activation of Th1 and Th2 cells in the immunopathogenesis of atopic eczema – the 2-phase model, Allergologie, 19, 449
  148. 10.1126/science.289.5484.1560 · DOI · Paper page
  149. 10.1038/43185 · DOI · Paper page
  150. 10.1053/gast.2000.9370 · DOI · Paper page
  151. 10.1016/j.tem.2003.09.008 · DOI · Paper page
  152. 10.1002/art.20499 · DOI · Paper page
  153. 10.1136/gut.2004.044834 · DOI · Paper page
  154. 10.1016/S0091-6749(96)80161-8 · DOI · Paper page
  155. 10.1053/j.gastro.2005.02.014 · DOI · Paper page
  156. 10.1136/thx.2004.039701 · DOI
  157. Postma, 2004, Clinical Respiratory Medicine, 457
  158. 10.1016/j.jaci.2005.09.039 · DOI
  159. 10.1136/gut.2004.043372 · DOI · Paper page
  160. 10.1093/ajcn/83.2.331 · DOI · Paper page
  161. 10.1093/ajcn/76.6.1249 · DOI · Paper page
  162. 10.1046/j.1365-2222.2000.00959.x · DOI · Paper page
  163. Geng, 1993, Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes, J Immunol, 151, 6692, 10.4049/jimmunol.151.12.6692 · DOI
  164. Scott, 1985, Age related changes of human serum antibodies to dietary and colonic bacterial antigens measured by an enzyme linked immunosorbent assay, Acta Pathol Microbiol Immunol Scand, 93, 65
  165. Ena, 1985, High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients, Acta Cardiol, 40, 199
  166. 10.1046/j.1467-789X.2001.00042.x · DOI · Paper page
  167. Randolph, 1999, Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma, J Immunol, 162, 2375, 10.4049/jimmunol.162.4.2375 · DOI · Paper page
  168. 10.1016/j.lfs.2003.06.036 · DOI
  169. 10.1161/01.RES.80.1.37 · DOI
  170. 10.1136/thorax.55.suppl_2.S51 · DOI
  171. 10.1111/j.1365-2249.1995.tb03836.x · DOI · Paper page
  172. 10.1016/S0140-6736(00)04168-4 · DOI · Paper page
  173. 10.1038/nature00878 · DOI · Paper page
  174. 10.1097/00054725-200502000-00001 · DOI
  175. 10.1136/thx.49.12.1205 · DOI
  176. 10.1016/j.ejphar.2005.12.087 · DOI · Paper page
  177. 10.1111/j.1574-695X.2001.tb01582.x · DOI
  178. 10.1046/j.1365-2796.1996.410753000.x · DOI
  179. 10.1079/BJN20041347 · DOI
  180. 10.1093/ajcn/85.6.1634 · DOI
  181. Famularo, 1997, Probiotics: therapeutic and Other Beneficial Effects, 133, 10.1007/978-94-011-5860-2_6 · DOI
  182. 10.1136/gut.52.2.237 · DOI · Paper page
  183. 10.1016/0006-2952(94)00433-M · DOI
  184. 10.1183/09031936.03.00405703 · DOI · Paper page
  185. 10.1034/j.1398-9995.2003.00161.x · DOI · Paper page
  186. 10.1111/j.1572-0241.2003.07384.x · DOI
  187. 10.1016/0021-9150(91)90235-U · DOI · Paper page
  188. 10.1183/09031936.05.00011205 · DOI
  189. 10.1038/emm.2006.27 · DOI
  190. 10.1038/ncpgasthep0111 · DOI
  191. 10.1210/en.2003-0870 · DOI · Paper page
  192. 10.1016/0021-9150(90)90039-L · DOI · Paper page
  193. 10.1136/thx.2004.030858 · DOI
  194. 10.1079/PNS2001110 · DOI · Paper page
  195. 10.1183/09031936.06.00056106 · DOI
  196. 10.1056/NEJM200008243430803 · DOI · Paper page
  197. 10.1038/ni0802-715 · DOI · Paper page
  198. 10.1006/bbrc.1999.0716 · DOI
  199. 10.1007/s11745-001-0666-z · DOI
  200. 10.1038/35021228 · DOI · Paper page

200 of 421 shown

Cited by

Metadata

Authors
Calder, P. C., Albers, R., Antoine, J.-M., Blum, S., Bourdet-Sicard, R., Ferns, G. A., Folkerts, G., Friedmann, P. S., Frost, G. S., Guarner, F., Løvik, M., Macfarlane, S., Meyer, P. D., M'Rabet, L., Serafini, M., van Eden, W., van Loo, J., Vas Dias, W., Vidry, S., Winklhofer-Roob, B. M., & Zhao, J.
Venue
British Journal of Nutrition
Publisher
Cambridge University Press (CUP)
Published
2009-05
Volume
101
Issue
S1
Pages
1-45
ISSN
  • 0007-1145 (ISSN-L)
  • 1475-2662
DOI
10.1017/s0007114509377867
OpenAlex
W2147370249
Cited by
568
References
37
FWCI
27.86
Type
journal article
Language
en
Open access
bronze
Licence
www.cambridge.org/core/terms (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.